EV/EBITDA
-0.27
NaN%
Thu, 06 Feb 2025 21:00:00 GMT
Summary
- As of February 12, 2025, EIGR EV/EBITDA is -0.27
- Over the past year, EIGR EV/EBITDA has stayed the same.
- EIGR EV/EBITDA is now -129.67% below its all-time high of 0.91.
Performance
EIGR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
EIGR EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
6 m6 months | +44.9% | -45.5% | -85.7% |
1 y1 year | 0.0% | -16.9% | -70.3% |
5 y5 years | +93.7% | -93.6% | -99.5% |
EIGR EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.27 | at low | |
3 m | 3-month | -0.27 | at high | -0.27 | at low |
6 m | 6-month | -0.27 | at high | -0.49 | +44.9% |
1 y | 1-year | -0.19 | -42.1% | -0.53 | +49.1% |
3 y | 3-year | -0.19 | -42.1% | -11.82 | +97.7% |
5 y | 5-year | -0.19 | -42.1% | -14.60 | +98.2% |
alltime | all time | 0.91 | -129.7% | -37.11 | +99.3% |
Eiger BioPharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -0.27(-6.9%) |
2023 | -0.29(-59.7%) |
2022 | -0.72(-88.8%) |
2021 | -6.43(-6.9%) |
2020 | -6.91(+28.0%) |
Date | Value |
---|---|
2019 | -5.40(+69.3%) |
2018 | -3.19(+0.3%) |
2017 | -3.18(+74.7%) |
2016 | -1.82(+857.9%) |
2015 | -0.19(-98.6%) |
2014 | -13.79 |
FAQ
- What is Eiger BioPharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals EV/EBITDA year-on-year change?
What is Eiger BioPharmaceuticals EV/EBITDA?
The current EV/EBITDA of EIGR is -0.27
What is the all time high EV/EBITDA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high EV/EBITDA is 0.91
What is Eiger BioPharmaceuticals EV/EBITDA year-on-year change?
Over the past year, EIGR EV/EBITDA has changed by 0.00 (0.00%)